Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nabriva Therapeutics AG (NBRV)  
$0.39 0.00 (0.00%) as of 4:30 Wed 12/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 150,780,000
Market Cap: 59.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3938 - $0.3938
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Nabriva Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company engaged in the research, development and commercialization of anti-infective agents to treat serious infections. Co. has approval from the U.S. Food and Drug Administration for XENLETA for the treatment of adults with community-acquired bacterial pneumonia. XENLETA is an oral and intravenous treatment in the pleuromutilin class of antibiotics available for the systematic administration in humans. Co.'s CONTEPO is a potentially epoxide antibiotic for intravenous use in the U.S. for complicated urinary tract infections. Co. may develop XENLETA and CONTEPO for additional indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 51,839
Total Sell Value $0 $0 $0 $9,588
Total People Sold 0 0 0 6
Total Sell Transactions 0 0 0 6
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 323
  Page 6 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Crotty Robert Gen Counsel & Corp Secretary   •       –      –    2021-03-06 4 D $1.79 $127 D/D (71) 41,748     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-03-06 4 D $1.79 $403 D/D (225) 178,760     -
   Crotty Robert Gen Counsel & Corp Secretary   •       –      –    2021-02-28 4 D $2.39 $91 D/D (38) 42,726     -
   Sender Gary Chief Financial Officer   •       –      –    2021-02-28 4 D $2.39 $74 D/D (31) 20,472     -
   Schranz Jennifer Chief Medical Officer   •       –      –    2021-02-28 4 D $2.39 $79 D/D (33) 39,125     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-02-28 4 D $2.39 $253 D/D (106) 181,787     -
   Gelone Steven P. President and COO   •       –      –    2021-02-28 4 D $2.39 $151 D/D (63) 78,091     -
   Gelone Steven P. President and COO   •       •      –    2021-02-06 4 D $2.90 $3,202 D/D (1,104) 76,924     -
   Crotty Robert Gen Counsel & Corp Secretary   •       –      –    2021-02-06 4 D $2.90 $2,523 D/D (870) 41,819     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-02-06 4 D $2.90 $7,816 D/D (2,695) 178,985     -
   Schranz Jennifer Chief Medical Officer   •       –      –    2021-01-31 4 D $2.62 $94 D/D (36) 39,158     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-01-31 4 D $2.62 $328 D/D (125) 181,893     -
   Sender Gary Chief Financial Officer   •       –      –    2021-01-31 4 D $2.62 $97 D/D (37) 20,503     -
   Gelone Steven P. President and COO   •       –      –    2021-01-31 4 D $2.62 $197 D/D (75) 78,154     -
   Crotty Robert Gen Counsel & Corp Secretary   •       –      –    2021-01-31 4 D $2.62 $113 D/D (43) 42,764     -
   Schranz Jennifer Chief Medical Officer   •       –      –    2021-01-29 4 A $0.00 $0 D/D 22,500 39,194     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-01-29 4 A $0.00 $0 D/D 117,500 182,018     -
   Gelone Steven P. President and COO   •       –      –    2021-01-29 4 A $0.00 $0 D/D 42,500 78,229     -
   Crotty Robert Gen Counsel & Corp Secretary   •       –      –    2021-01-29 4 A $0.00 $0 D/D 22,500 42,807     -
   Crotty Robert Gen Counsel & Corp Secretary   •       –      –    2020-12-31 4 D $2.42 $90 D/D (37) 20,307     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2020-12-31 4 D $2.42 $293 D/D (121) 64,518     -
   Sender Gary Chief Financial Officer   •       –      –    2020-12-31 4 D $2.42 $77 D/D (32) 20,540     -
   Schranz Jennifer Chief Medical Officer   •       –      –    2020-12-31 4 D $2.42 $73 D/D (30) 16,694     -
   Gelone Steven P. President and COO   •       –      –    2020-12-31 4 D $2.42 $152 D/D (63) 35,729     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2020-11-30 4 D $0.43 $517 D/D (1,211) 646,396     -
  323 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us